Product Overview

AOP Orphan's focus is on Rare Diseases. The portfolio comprises products in the following therapeutic areas: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.

HematoOncology

Thromboreductin®

is used to reduce an elevated blood platelet count, thrombocyte count, in patients with essential thrombocythemia.

Drug Facts
Active Ingredient
Anagrelide